Vorasidenib in IDH mutant WHO grade 2 gliomas: time to stop sitting on the fence?

Neurooncol Adv. 2024 Jan 9;6(1):vdae003. doi: 10.1093/noajnl/vdae003. eCollection 2024 Jan-Dec.

Authors

Angelo Dipasquale¹, Enrico Franceschi², Giuseppe Lombardi³, Matteo Simonelli^{1

4}

Affiliations

¹ Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
² Department of Medical Oncology, IRCCS Institute of Neurological Sciences, Bologna, Italy.
³ Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
⁴ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.

No abstract available

Publication types

Editorial